Subtopic Deep Dive
Dilated Cardiomyopathy Genetic Basis
Research Guide
What is Dilated Cardiomyopathy Genetic Basis?
Dilated cardiomyopathy genetic basis examines truncating variants in titin, lamin, and filamin C genes that drive DCM progression to heart failure through inheritance patterns and incomplete penetrance.
Over 7,855 cardiomyopathy cases revealed reassessment of Mendelian gene pathogenicity, identifying truncating variants in TTN as common in DCM (Walsh et al., 2016, 738 citations). Truncating FLNC mutations associate with high-risk DCM and arrhythmogenic phenotypes (Ortiz-Genga et al., 2016, 455 citations). Expert consensus outlines genetic testing protocols for cardiomyopathies including DCM (Ackerman et al., 2011, 896 citations).
Why It Matters
Genetic identification of TTN truncations enables family cascade screening, reducing sudden cardiac death risk in relatives (Walsh et al., 2016). FLNC variants predict aggressive DCM with arrhythmias, guiding implantable defibrillator decisions (Ortiz-Genga et al., 2016). Consensus statements standardize testing, improving diagnosis accuracy across 2,912 probands (Ackerman et al., 2011; Alfares et al., 2015). These advances inform CRISPR-based therapies targeting sarcomeric genes in DCM.
Key Research Challenges
Variant Pathogenicity Reassessment
Interpreting rare variants in 7,855 cases against 60,706 controls challenges Mendelian classifications for DCM genes like TTN (Walsh et al., 2016). Incomplete penetrance complicates causality attribution. Standardized reanalysis pipelines are needed.
Filamin C Truncation Effects
FLNC truncations link to high-risk DCM and arrhythmogenic overlap in cohorts, but mechanistic impacts on cytoskeleton remain unclear (Ortiz-Genga et al., 2016). Phenotype prediction across families varies. Longitudinal studies are required.
Genetic Testing Yield Limits
Expanded panels in 2,912 hypertrophic cases yield limited sensitivity for DCM-related genes, highlighting panel design flaws (Alfares et al., 2015). Overlap with other cardiomyopathies confuses diagnosis. Consensus updates are essential (Ackerman et al., 2011).
Essential Papers
Duchenne muscular dystrophy
Dongsheng Duan, Nathalie Goemans, Shin’ichi Takeda et al. · 2021 · Nature Reviews Disease Primers · 1.2K citations
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)
Michael J. Ackerman, Silvia G. Priori, Stephan Willems et al. · 2011 · EP Europace · 896 citations
PreambleThis international consensus statement provides the state of genetic testing for the channelopathies and cardiomyopathies.It summarizes the opinion of the international writing group member...
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy
Jeffrey A. Towbin, William J. McKenna, Dominic J. Abrams et al. · 2019 · Heart Rhythm · 765 citations
Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples
Roddy Walsh, Kate Thomson, James S. Ware et al. · 2016 · Genetics in Medicine · 738 citations
Dilated cardiomyopathy
Heinz‐Peter Schultheiß, DeLisa Fairweather, Alida L.P. Caforio et al. · 2019 · Nature Reviews Disease Primers · 632 citations
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies
Martín Ortiz-Genga, Sofía Cuenca, Matteo Dal Ferro et al. · 2016 · Journal of the American College of Cardiology · 455 citations
Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity
Ahmed Alfares, Melissa Kelly, Gregory C McDermott et al. · 2015 · Genetics in Medicine · 441 citations
Reading Guide
Foundational Papers
Start with Ackerman et al. (2011, 896 citations) for genetic testing consensus in cardiomyopathies including DCM protocols. Follow with Olson et al. (2002, 278 citations) on metavinculin mutations altering actin in DCM.
Recent Advances
Study Walsh et al. (2016, 738 citations) for pathogenicity reassessment in large cohorts and Ortiz-Genga et al. (2016, 455 citations) for FLNC high-risk variants.
Core Methods
High-throughput sequencing panels (Alfares et al., 2015), variant reassessment via reference cohorts (Walsh et al., 2016), and segregation analysis in families (Ackerman et al., 2011).
How PapersFlow Helps You Research Dilated Cardiomyopathy Genetic Basis
Discover & Search
Research Agent uses searchPapers and citationGraph to map TTN truncating variants literature from Walsh et al. (2016), then exaSearch uncovers 50+ related DCM genetics papers, and findSimilarPapers reveals FLNC studies like Ortiz-Genga et al. (2016).
Analyze & Verify
Analysis Agent applies readPaperContent on Walsh et al. (2016) abstracts to extract pathogenicity scores, verifyResponse with CoVe checks variant classifications against Ackerman et al. (2011) consensus, and runPythonAnalysis computes penetrance statistics from cohort data using pandas. GRADE grading scores evidence strength for TTN in DCM.
Synthesize & Write
Synthesis Agent detects gaps in FLNC-DCM overlap therapies and flags contradictions between Walsh et al. (2016) and Alfares et al. (2015) panel yields; Writing Agent uses latexEditText, latexSyncCitations for TTN review manuscripts, and latexCompile generates polished PDFs with exportMermaid diagrams of inheritance patterns.
Use Cases
"Analyze penetrance of TTN truncations in DCM families from recent cohorts"
Research Agent → searchPapers('TTN DCM penetrance') → Analysis Agent → runPythonAnalysis (pandas on cohort stats from Walsh 2016) → statistical penetrance plot and p-values.
"Draft LaTeX review on FLNC mutations in high-risk DCM"
Synthesis Agent → gap detection (FLNC therapies) → Writing Agent → latexEditText (intro) → latexSyncCitations (Ortiz-Genga 2016) → latexCompile → camera-ready PDF with citations.
"Find GitHub code for DCM genetic variant analysis pipelines"
Research Agent → paperExtractUrls (Walsh 2016) → Code Discovery → paperFindGithubRepo → githubRepoInspect → verified pipelines for variant reassessment.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ DCM genetics papers, chaining searchPapers → citationGraph → DeepScan for 7-step verification on TTN pathogenicity (Walsh et al., 2016). Theorizer generates hypotheses on FLNC-DCM mechanisms from Ortiz-Genga et al. (2016) abstracts, outputting Mermaid inheritance models. DeepScan applies CoVe checkpoints to consensus testing protocols (Ackerman et al., 2011).
Frequently Asked Questions
What defines the genetic basis of dilated cardiomyopathy?
Truncating variants in TTN, LMNA, and FLNC genes cause DCM via sarcomere disruption and cytoskeletal instability (Walsh et al., 2016; Ortiz-Genga et al., 2016). Inheritance shows autosomal dominant patterns with incomplete penetrance.
What methods assess gene pathogenicity in DCM?
Reanalysis of 7,855 cases uses allele frequency comparisons and segregation studies (Walsh et al., 2016). Panels sequence 40+ genes but yield varies (Alfares et al., 2015). Consensus recommends trio testing (Ackerman et al., 2011).
What are key papers on DCM genetics?
Walsh et al. (2016, 738 citations) reassesses pathogenicity; Ortiz-Genga et al. (2016, 455 citations) links FLNC truncations to high-risk DCM; Ackerman et al. (2011, 896 citations) provides testing consensus.
What open problems exist in DCM genetic basis?
Incomplete penetrance mechanisms for TTN variants need elucidation (Walsh et al., 2016). FLNC phenotype predictors across cardiomyopathies remain unclear (Ortiz-Genga et al., 2016). Therapeutic targeting of truncations lacks trials.
Research Cardiomyopathy and Myosin Studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Dilated Cardiomyopathy Genetic Basis with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Cardiomyopathy and Myosin Studies Research Guide